OFAC FAQ (Current) # 104 - Compliance for the Insurance Industry [PDF contains amended version(s)]

Date issued: Nov. 13 2024

Last substantive commentary amendment:
Nov. 15 2024

TURBOFAC Commentary (291 words)

Notes:

1) OFAC acknowledges that the issue of travel insurance is ordinarily incident to travel (where travel is exempt).

2) While there are no Crimea embargo regulations to say so explicitly, OFAC's statement here presumably applies to the Crimea embargo as well, seeing as it was enacted under IEEPA and the source of the authorization for the issue of global travel insurance is that it is ordinarily incident to travel exempt from regulation under IEEPA. This FAQ was issued/last updated subsequent to the issue of EO 13685.

3) The North Korean sanctions regulations also exempt transactions "ordinarily incident to travel" even though travel to North Korea has been effectively barred through non-sanctions-based means (i.e. special passport requirements).

4) FAQ amended on 11-13-24 to specify that “[t]he authority granted to the President by the International Emergency Economic Powers Act (IEEPA) does not include the authority to regulate or prohibit, directly or indirectly, transactions ordinarily incident to travel to or from any country,” such that regulations and EOs need not make any specific reference to the travel exemption for it to apply. See generally General Note on the Applicability of IEEPA/TWEA Exemptions in EOs and Sanctions Regulations not Specifically Mentioning Them.

5) FAQ amended to specify that “the issuance and provision of travel-related insurance coverage related to exempt travel,” i.e. it is not only in the context of “global travel insurance and worldwide travel assistance” that such insurance is exempt from regulation. (See Notable Examples Illustrating the Scope of the Travel Exemption).


6) FAQ amended on 11-13-24 to clarify that the provision of travel insurance coverage related to authorized travel to Cuba is a “travel-related service” (for purposes of 515.572 of the CACR).